# AMOXICILLIN AND CLAVULANATE POTASSIUM
> **ANDA209371** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2019-04-19
## Drug
- **FDA Application Number:** ANDA209371
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMOXICILLIN AND CLAVULANATE POTASSIUM
- **Generic name:** AMOXICILLIN AND CLAVULANATE POTASSIUM
- **Active ingredients:** AMOXICILLIN; CLAVULANATE POTASSIUM
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2019-04-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209371)
---
*AI Analytics · CC0 1.0*